Yangbo Feng

Years Active: 2021-2024
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Sana Chaudhry, Jesus R Castro, Tulasigeri M Totiger, Jumana Afaghani, Rabia Khurshid, Miah Nicholls, Ziming Zhang, Stephan C Schürer, Ashish Shah, Justin Taylor, Yangbo Feng
Potent, Selective, and Orally Bioavailable Quinazoline-Based STK17A/B Dual Inhibitors. ACS medicinal chemistry letters 15 (6) (2024)
Sana Chaudhry, Jesus R Castro, Tulasigeri M Totiger, Jumana Afaghani, Rabia Khurshid, Miah Nicholls, Ziming Zhang, Stephan C Schürer, Ashish Shah, Justin Taylor, Yangbo Feng
Potent, Selective, and Orally Bioavailable Quinazoline-Based STK17A/B Dual Inhibitors. ACS medicinal chemistry letters 15 (6) (2024)
Yangbo Feng, HaJeung Park, Jae Cheon Ryu, Sung Ok Yoon
N-Aromatic-Substituted Indazole Derivatives as Brain-Penetrant and Orally Bioavailable JNK3 Inhibitors. ACS medicinal chemistry letters 12 (10) (2021)

Yangbo Feng.css-eqlu8i{font-size:small;padding-left:4px;}